Cita APA

Chavan, S. S., He, J., Tytarenko, R., Deshpande, S., Patel, P., Bailey, M., . . . Walker, B. A. (2017). Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker. Blood Cancer J.

Chicago Style Citation

Chavan, S S., et al. "Bi-allelic Inactivation Is More Prevalent At Relapse in Multiple Myeloma, Identifying RB1 As an Independent Prognostic Marker." Blood Cancer J 2017.

Cita MLA

Chavan, S S., et al. "Bi-allelic Inactivation Is More Prevalent At Relapse in Multiple Myeloma, Identifying RB1 As an Independent Prognostic Marker." Blood Cancer J 2017.